COSCIENS Biopharma Appoints Peter H. Puccetti as Interim CEO
I'm PortAI, I can summarize articles.
07:44 AM EST, 11/17/2025 (MT Newswires) -- COSCIENS Biopharma ( CSCIF ) , which rose 3.15% on Friday, announced over the weekend that the chairman of its board of directors, Peter H. Puccetti, has been appointed as the company's interim chief executive, effective immediately.Puccetti expands his role with this appointment and succeeds Anna Biehn, who has stepped down as CEO.Shares of the company were last seen up $0.1 to $3.3 on Friday on the Toronto Stock Exchange. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.
Source: fidelity The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments